Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Innopep Inc.
San Diego, United States
B
1-10 Employees
2012
Key takeaway
InnoPep specializes in high-quality long peptide synthesis of up to 100 amino acids, making it well-equipped to meet diverse peptide therapeutic needs. With a commitment to timely delivery and a supportive team, InnoPep ensures that customer requests are addressed effectively throughout the process.
Reference
Service
Peptide Services - InnoPep
Therapeutic Peptides
Baton Rouge, United States
B
1-10 Employees
1992
Key takeaway
Therapeutic Peptides, Inc. (TPI) specializes in designing and integrating innovative oligopeptides and lipopeptides into formulations for the personal healthcare and pharmaceutical industries. Their patented biosurfactant technology enhances metabolic bioactivity and transdermal delivery, making their peptide-based solutions valuable for commercial applications.
Reference
Core business
Innovation in Peptides - Therapeutic Peptides, Inc.
TPI offers a wide selection of performance-enhancing dermally active peptides, peptide derivatives, and new technologies to product formulators and
Creative Peptides
New York, United States
B
1-10 Employees
2005
Key takeaway
Creative Peptides specializes in custom peptide synthesis and the manufacturing of bioactive peptides, offering a range of therapeutic peptides and innovative strategies for their development and analysis. Their expertise includes the production of antimicrobial peptides and other biologically active peptides, making them a key player in the peptide therapeutics field.
Reference
Product
Therapeutic Peptides - Creative Peptides
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Peptide Logic
San Diego, United States
B
1-10 Employees
2013
Key takeaway
Peptide Logic is focused on developing innovative peptide-based drugs, particularly in pain management and other therapeutic areas, by leveraging synthetic peptides and recombinant antibodies to create unique peptide-antibody conjugates. Their commitment to advancing peptide therapeutics is evident in their multi-product pipelines and comprehensive technology platform.
Reference
Core business
Peptide I San Diego I Peptide Logic
Peptide Logic is a biopharmaceutical company combining the advantages of synthetic peptides and recombinant antibodies to create transformative peptide-antibody conjugates (PACs) for pain and other selected therapeutic areas.
Polypeptide
Braine-l'Alleud, Belgium
A
251-500 Employees
2006
Key takeaway
PolyPeptide Group AG is a specialized Contract Development & Manufacturing Organization (CDMO) that focuses on the development and manufacturing of synthetic peptides and oligonucleotides, which are essential active pharmaceutical ingredients (API) in therapeutic products. With a commitment to supporting pharmaceutical and biotech companies, PolyPeptide plays a crucial role in the production of peptide-based APIs, contributing to the health of millions of patients worldwide.
Reference
Core business
PolyPeptide - Peptides, Peptide Synthesis and Custom Peptide Synthesis
PolyPeptide Labs is a world leader in the manufacture of polypeptide, custom peptide Synthesis, peptide synthesis and generic peptide : generic GMP peptide and non-GMP peptide. PolyPeptide provides global support for a quality solution.
PEP-Therapy
Évry, France
A
1-10 Employees
2014
Key takeaway
PEP-Therapy is a French biotechnology company focused on developing innovative peptides as targeted therapies for oncology. Their lead candidate, PEP-010, is a pro-apoptotic agent that has shown anti-tumor efficacy in pre-clinical models and is currently undergoing Phase Ia clinical trials.
Reference
Core business
PEP-Therapy, Innovative peptides as targeted therapies for oncology
PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Longevity Biotech
Philadelphia, United States
B
1-10 Employees
2010
Key takeaway
Longevity Biotech is dedicated to advancing peptide therapeutics through its innovative Hybridtide® scaffold, which enhances the stability and efficacy of peptide drugs. Their expert team is focused on developing clinically transformative products and advancing them through preclinical and clinical trials.
Reference
Core business
Longevity Biotech, Inc | Longevity Biotech, Inc
Longevity Biotech, Inc
JPT Peptide Techologies
Berlin, Germany
A
101-250 Employees
2004
Key takeaway
JPT Peptide Technologies is a leading manufacturer of custom peptides and innovative peptide-based products for research and clinical applications. With over 15 years of experience and ISO 9001:2015 certification, the company offers reliable custom and catalog peptides, peptide microarrays, and libraries, particularly for immunology and proteomics.
Reference
Core business
Visit the Peptide Expert: JPT Peptide Technologies; ISO 9001 certified
Reliable custom & catalog peptides, peptide microarrays, peptide pools & libraries for immunology e.g. immune monitoring & epitope identification, and proteomics. Contact us!
Arta Peptidion
Italy
B
1-10 Employees
-
Key takeaway
Arta Peptidion is a biotechnology company focused on the research and development of bioactive peptides and peptidomimetics, particularly for pharmaceutical applications. With a commitment to innovation, they aim to create first-in-class therapeutic peptides that address the evolving needs of the pharmaceutical and veterinary sectors.
Reference
Core business
Custom Designed Peptides and Bioactive Peptidomimetics | Arta Peptidion
Arta Peptidion is a private biotechnology company for the research and the development of Peptides and Bioactive Peptidomimetics. Download our Brochure.
Sapience Therapeutics
Village of Scarsdale, United States
B
1-10 Employees
2015
Key takeaway
Sapience Therapeutics is focused on developing first-in-class peptide antagonists, specifically their innovative SPEARs™ (Stabilized Peptides Engineered Against Regulation), targeting challenging oncogenic and immune-modulating drug targets. Their commitment to peptide innovation aims to create new therapies for various cancers.
Reference
Core business
About - Sapience Therapeutics
Here
Technologies which have been searched by others and may be interesting for you:
Peptide therapeutics are medical treatments that utilize peptides, which are short chains of amino acids. These compounds can mimic the action of natural hormones and proteins in the body, offering therapeutic effects for various conditions. They are increasingly used in drug development due to their specificity and potency, making them effective in targeting particular biological pathways. The growing interest in peptide therapeutics is attributed to their ability to treat diseases such as diabetes, cancer, and cardiovascular disorders. Additionally, their favorable safety profile and reduced side effects compared to traditional small-molecule drugs enhance their appeal in the pharmaceutical industry. As research continues, the potential applications for peptide-based therapies expand, paving the way for innovative treatment options.
Peptide therapeutics function by mimicking or influencing the actions of naturally occurring peptides in the body. These short chains of amino acids can interact with specific receptors on cell surfaces, triggering biological responses that can help regulate various physiological processes. For instance, they may enhance insulin sensitivity, modulate immune responses, or promote tissue repair and regeneration. When introduced into the body, peptide therapeutics can bind to target receptors with high specificity, leading to precise and effective treatment outcomes. This targeted action minimizes side effects often associated with traditional drugs, making peptide therapeutics a promising avenue in modern medicine for conditions like diabetes, cancer, and metabolic disorders.
1. Targeted Action
Peptide therapeutics are designed to specifically target certain biological pathways or receptors, allowing for precise intervention in disease processes. This targeted action often results in enhanced efficacy and reduced side effects compared to traditional small molecule drugs.
2. Safety Profile
The safety profile of peptide therapeutics is generally favorable. They are often derived from naturally occurring peptides in the body, which can lead to better tolerance and lower risk of adverse reactions. This characteristic makes them an attractive option for long-term therapies.
3. Versatility
Peptide therapeutics can be utilized in a wide range of medical applications, including cancer treatment, metabolic disorders, and autoimmune diseases. Their versatility allows for the development of specialized treatments tailored to individual patient needs.
4. Stability and Delivery
Recent advancements in formulation techniques have improved the stability and delivery methods for peptide therapeutics. This progress allows for various administration routes, such as injectable, oral, or nasal, enhancing patient compliance and convenience.
Peptide therapeutics have shown promise in treating a variety of conditions due to their ability to target specific biological pathways.
1. Metabolic Disorders
These therapeutics can assist in managing diabetes by enhancing insulin sensitivity and regulating blood sugar levels.
2. Hormonal Imbalances
They are effective in addressing hormonal issues, including growth hormone deficiencies and reproductive hormone disorders.
3. Cardiovascular Diseases
Peptide therapeutics can play a role in managing cardiovascular conditions by improving heart function and reducing blood pressure.
4. Neurological Disorders
Certain peptides have potential in treating neurodegenerative diseases, such as Alzheimer's, by promoting neuronal health and reducing inflammation.
5. Autoimmune Diseases
These treatments may help modulate immune responses in conditions like rheumatoid arthritis and lupus, thereby reducing symptoms and improving quality of life.
Peptide therapeutics can lead to various side effects, although many patients tolerate them well. Common side effects may include injection site reactions, such as redness, swelling, or pain at the injection site. Other potential effects can be gastrointestinal disturbances, including nausea or diarrhea, depending on the specific peptide used. In some cases, allergic reactions may occur, which can manifest as rashes or more severe symptoms. It's essential for patients to discuss any pre-existing conditions or allergies with their healthcare provider to minimize risks and ensure safe administration of peptide therapies.
Some interesting numbers and facts about your company results for Peptide Therapeutics
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 10000 |
| Amount of suitable service providers | 7942 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 1992 |
| Youngest suiting company | 2015 |
20%
40%
60%
80%
Some interesting questions that has been asked about the results you have just received for Peptide Therapeutics
What are related technologies to Peptide Therapeutics?
Based on our calculations related technologies to Peptide Therapeutics are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Peptide Therapeutics?
The most represented industries which are working in Peptide Therapeutics are Biotechnology, Other, Pharmaceuticals, Medical, Healthcare
How does ensun find these Peptide Therapeutics Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.